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SubtractionAbstract Background: Subtraction imaging is a technique whereby an unenhanced T1-weighted
sequence is digitally subtracted from the identical sequence performed after gadolinium administra-
tion.
Aim of the work: This study will highlight the role of subtraction imaging for non-vascular MRI
applications.
Subjects and methods: The study included 40 patients presenting with lesions in different parts of
the body, that are initially hyperintense on T1W sequences.
We used post-processing software (Osirix) to digitally subtract the pre-enhancement from the post
enhancement sequences.
Results: Based on subtraction imaging ﬁndings 5 patients were diagnosed with intraocular melano-
mas, two patients were diagnosed with hemorrhagic cysts in the masseter muscle , two patients were
diagnosed with hemorrhagic cysts in the parotid gland, two patients were diagnosed with dysplastic
hepatic nodules, 5 patients were diagnosed with post-ablation necrosis following hepatocellular car-
cinoma (HCC) treatment, two patients showed recurrent HCC after chemoembolisation, 3 patients
showed chemoembolised HCC without recurrence, 4 patients showed intraluminal gall bladder
sludge, 4 patients showed hemorrhagic renal cysts, one patient showed solid papillary neoplasm
of the pancreas, 6 patients showed chocolate ovarian cysts, two patient showed ovarian
cystadenoma and two patients showed ovarian cystadenocarcinoma.
Conclusion: Subtraction MRI is very helpful tool in non-vascular MRI applications.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
Subtraction imaging is a readily available technique that is
routinely used in MR angiography. It may be still underused
in routine body MR applications. It is simply a technique
whereby an unenhanced T1-weighted sequence is digitally
subtracted from the identical sequence performed after
gadolinium administration. By performing this operation,
any native T1 signal is removed and the remaining signal on
910 M. Eid, A. Abougabalthe subtracted images is due solely to enhancement. There are
many potential applications for this technique including eval-
uating for the presence of a neoplasm in hemorrhagic masses,
complicated cysts, and other settings in which determining theFig. 1 Pre and postcontrast enhanced T1W MRI images (A and B) o
along the lateral aspect of the choroidal lining of the left globe. Subtra
its neoplastic nature. The lesion was histopathologically proven to be
Table 1 Shows the distribution of the 40 patients included in this stu
pathological diagnosis.
Type of lesion Enhanceme
Choroidal melanoma Positive
Hemorrhagic masseter cyst Absent
Hemorrhagic Parotid cyst Absent
Dysplastic hepatic nodule Absent
HCC (post-ablation necrosis) Absent
HCC (recurrent after chemoembolization) Positive
HCC (chemoembolized without recurrence) Absent
Gall bladder sludge Absent
Hemorrhagic renal cyst Absent
Solid papillary neoplasm of pancreas Tiny enhan
Ovarian chocolate cyst Absent
Ovarian cystadenoma Internal en
Ovarian cystadenocarcinoma Solid enhanpresence or absence of enhancement is critical. Qualitative
detection of enhancement within such lesions is often not a
straightforward task due to hemorrhagic or proteinaceous
contents making them hyperdense on CT or high signal onf the left orbit showing an initially hyperintense intraocular lesion
ction image (C) shows positive enhancement of the lesion denoting
choroidal melanoma.











cing papilla 1 2.5
6 15
hancing septations 2 5
cing mural nodules 2 5
Subtraction imaging 911unenhanced T1-weighted MRI pulse sequences. Subtraction
imaging can make evaluation of these lesions more straightfor-
ward. Its use in non vascular MRI applications has not been
widely discussed in the radiological literature (1–4).
This study will highlight the role of subtraction imaging for
non-vascular MRI applications.
2. Materials and methods
This retrospective study included 40 patients presenting with
lesions in different parts of the body, that are initially hyperin-
tense on T1W sequences, and in whom visual assessment of
enhancement is difﬁcult.
Different types of MRI exams were included (heteroge-
neous sample) to show the utility of the post-processing tech-
nique, irrespective of the body part under study. All the
studies were performed on a 1.5 T closed magnet MRI
machine (Avanto, Siemens, Erlangen, Germany). We used a
set of 8-channel phased array coils dedicated to different body
parts included in the study.
An integral step of the MRI technique is the exact similarity
in all parameters (FOV, slice thickness, TR, TE, fat suppres-
sion . . .etc.) between both sequences to be subtracted, i.e.
pre- and post Gadolinium sequences.
The data sets were then transferred to an ofﬂine post-
processing workstation (Osirix: Version 4.1.2; www.osirix-Fig. 2 Pre and postcontrast enhanced T1W MRI images with fat su
lesion in the right masseter muscle. Subtraction image (C) shows abse
cystic nature. Diagnosis of hemorrhagic cyst was conﬁrmed histopathviewer.com) to digitally subtract the pre-enhancement from
the post enhancement sequences.
Objective visual assessment of the subtraction image was
used to assess enhancement: If no enhancement is noted, there
would be a signal void in the corresponding voxel. Any
visually detectable signal on this image would thus represent
enhancement.
The studies were viewed twice by both authors separately.
In the ﬁrst interpretation session, only the original dataset
was shown, without the subtraction images. Each author was
required to note whether the initially T1 hyperintense lesion
was ‘‘enhancing’’, ‘‘not enhancing’’ or ‘‘indeterminate’’. Then
after one month, and in a different randomized order, the
cases where visualized again with the help of the subtraction
images, and each author had again to classify the lesion as
‘‘enhancing’’, ‘‘not enhancing’’ or ‘‘indeterminate.’’
The ﬁnal diagnosis was reached in all cases through
histopathological/cytological evidence, either after surgical
excision of the lesion, image-guided biopsy or FNAC of its
ﬂuid contents.
3. Results
This study included 40 patients presenting with lesions in
different parts of the body all showing a hyperintense signal
in the non contrast enhanced T1W scans. Subtraction imagesppression (A and B) of the face showing an initially hyperintense
nce of enhancement within the lesion suggesting its hemorrhagic
ologically.
Fig. 3 MRI images of the liver: precontrast T1W image with fat suppression (A) and postcontrast T1W image in the arterial phase of
enhancement with fat suppression (B) showing an initially hyperintense large nodule in the right lobe of a cirrhotic liver (arrow).
Subtraction image shows absence of enhancement within the lesion. The possibility of a large dysplastic nodule rather than hepatocellular
carcinoma was suggested. Diagnosis was conﬁrmed histopathologically via ultrasound guided biopsy.
912 M. Eid, A. Abougabalwere obtained after intravenous contrast injection to be able to
assess the presence of enhancement for adequate detection of
the nature of these lesions.
During the ﬁrst session of interpretation, all lesions were
categorized as ‘‘indeterminate’’ by both authors. With the help
of subtraction data sets in the second interpretation session,
they were easily categorized as either ‘‘enhancing’’ or ‘‘not
enhancing’’. Any gray scale value in the lesion other than com-
plete signal void on the post-processed subtraction image was
considered as ‘‘enhancement.’’
Out of these 40 patients, 5 patients (12.5%) presented with
intraocular lesions, two patients (5%) presented with lesions in
the masseter muscle, two patients (5%) presented with lesions
in the parotid gland, 12 patients (30%) presented with hepatic
lesions, four patients (10%) presented with gall bladder
lesions, four patients (10%) presented with renal lesions, one
patient (2.5%) presented with pancreatic lesion and ten
patients (25%) presented with ovarian lesions (Table 1).
Five patients presented with T1W hyperintense intraocular
lesions all of which were located along the choroidal lining of
the globe. Subtraction images conﬁrmed the presence of
enhancement within the lesions denoting their neoplastic nat-
ure and differentiating them from suprachoroidal hemorrhage.
The diagnosis of choroidal melanoma was conﬁrmed histopa-
thologically in all of the ﬁve patients (Fig. 1).
Two patients presented with T1W hyperintense lesions in
the masseter muscle. Subtraction images showed absence ofenhancement within the lesions suggesting their hemorrhagic
cystic nature. The diagnosis of hemorrhagic cysts was con-
ﬁrmed histopathologically in both patients (Fig. 2).
Two patients presented with T1W hyperintense lesions in
the parotid gland. Subtraction images showed absence of
enhancement within the lesions suggesting their hemorrhagic
cystic nature. The diagnosis of hemorrhagic cysts was con-
ﬁrmed histopathologically in both patients.
Twelve patients presented with hepatic focal lesions all
which on background of cirrhotic liver all showing a T1 hyper-
intense signal. Subtraction of non-contrast enhanced T1W
images from post-contrast T1W images in the arterial phase
was obtained in all patients. Two patients presented with T1
hyperintense large hepatic nodules with absence of enhance-
ment in the arterial phase suggesting the possibility of regener-
ating/low grade dysplastic nodules (low grade dysplasia shows
no enhancement, as opposed to high grade dysplastic nodules).
This was conﬁrmed via ultrasound guided biopsy in both
patients (Fig. 3).
Five patients had lesions with previous diagnosis of hepato-
cellular carcinoma managed by radiofrequency ablation with
absence of enhancement in the arterial phase as conﬁrmed
by the subtraction images suggesting the diagnosis of post-
ablation necrosis (Fig. 4).
Five patients had lesions with previous diagnosis of hepato-
cellular carcinoma managed by chemoembolization showing
retained T1 hyperintense lipidol particles out of which two
Fig. 4 Patient with history of right hepatic lobe hepatocellular carcinoma managed by radiofrequency ablation. MRI images of the liver:
precontrast T1W image with fat suppression (A) and postcontrast T1W image in the arterial phase of enhancement with fat suppression
(B) showing the previously ablated mass exhibiting an initially hyperintense signal. Subtraction image (C) shows absence of enhancement
within the mass conﬁrming the diagnosis of post-ablation necrosis and excluding the possibility of recurrence.
Subtraction imaging 913patients showed positive enhancement of the lesions in the
arterial phase denoting tumor recurrence (Fig. 5) and three
patients had absent enhancement denoting absence of recur-
rent active tumor tissue (Fig. 6).
Four patients presented with T1W hyperintense lesions
within the gall bladder lumen. In all of the four patients sub-
traction images showed absence of enhancement within the
lesions conﬁrming the diagnosis of intraluminal biliary sludge
and excluding the presence of a neoplastic process (Fig. 7).
Four patients presented with T1W hyperintense renal corti-
cal lesions. Subtraction images showed absence of enhance-
ment within the lesions conﬁrming the diagnosis of
hemorrhagic cortical renal cysts (Fig. 8).
One patient presented with a lesion within the tail of pan-
creas exhibiting a T1W hyperintense signal denoting high pro-
teinaceous content. Subtraction image conﬁrmed absence of
enhancement within the lesion apart from tiny enhancing pap-
illary projections seen along its left lateral wall. The diagnosis
of solid papillary neoplasm was conﬁrmed histopathologically
(Fig. 9).
Ten patients presented with T1W hyperintense ovarian cys-
tic lesions including six patients with ﬁnal pathological diagno-
sis of chocolate cysts, two patients with pathological diagnosis
of mucinous cystadenoma and two patients with pathological
diagnosis of mucinous cystadenocarcinoma. Subtraction
images showed absent enhancement in the lesions in the six
patients with diagnosis of chocolate cyst (Fig. 10).The lesions in the two patients diagnosed with mucinous
cystadenoma showed internal thin enhancing septations within
the lesions with absent enhancing solid component (Fig. 11)
while the lesions in the two patients diagnosed with mucinous
cystadenocarcinoma showed multiple mural solid enhancing
nodules seen along the walls of the lesions (Fig. 12).4. Discussion
The study included 40 patients presenting with lesions in dif-
ferent parts of the body, that are initially hyperintense on
T1W sequences, and in whom visual assessment of enhance-
ment is difﬁcult and is crucial for detection of nature of these
lesions. Digital subtraction of T1W unenhanced images from
similar contrast images was performed in all patients. Lee
et al. (3) and Newatia et al. (4) found that subtraction tech-
nique is valuable in MR imaging and could adequately deter-
mine the degree of contrast enhancement on background of
tissues which show a T1W hyperintense signal in the non con-
trast enhanced images like in hemorrhagic lesions or cystic
lesions with mucinous or high proteinaceous contents. This
agrees with the ﬁndings in our study in which such technique
was able to provide adequate qualitative assessment of
enhancement within all the lesions included within the study
and was able to differentiate between non neoplastic cystic
lesions with hemorrhagic or high proteinaceous contents with
Fig. 5 Patient with history of left hepatic lobe hepatocellular carcinoma managed by chemo-embolization. MRI images of the liver:
precontrast T1W image with fat suppression (A) and postcontrast T1W image in the arterial phase of enhancement with fat suppression
(B) showing a hyperintense signal within the lesion in both images. Subtraction image (C) shows positive enhancement within the lesion
notably along its margins conﬁrming tumor recurrence.
Fig. 6 Patient with history of right hepatic lobe hepatocellular carcinoma managed by chemo-embolization. MRI images of the liver:
precontrast T1W image with fat suppression (A) and postcontrast T1W image in arterial phase of enhancement with fat suppression (B)
showing the previously managed mass exhibiting a heterogeneous signal with hyperintense foci in both images likely due to retained lipidol
particles. Hypointense foci are also seen within the mass likely due to air. Subtraction image (C) shows absence of enhancement within the
mass conﬁrming the absence of recurrent active neoplastic tissue.
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Fig. 7 Patient with history of cholecystitis: MRI images of the gall bladder: precontrast T1W image with fat suppression (A) and
postcontrast T1W image in the arterial phase of enhancement with fat suppression (B) showing a lesion within the gall bladder lumen
exhibiting a hyperintense signal in both images. Subtraction image (C) shows absence of enhancement within the lesion conﬁrming the
diagnosis of intraluminal biliary sludge and excluding the presence of a neoplastic process.
Subtraction imaging 915absent enhancement and neoplastic lesions which showed solid
enhancing components.
In the cirrhotic liver, a nodule that exhibits enhancement
greater than that of background liver on arterial-dominant
gadolinium-enhanced images is presumed to be a hepatocellu-
lar carcinoma because this degree of enhancement is infre-
quently seen in dysplastic nodules and rarely seen in
regenerative nodules. However, regenerative and dysplastic
nodules and hepatocellular carcinoma can all exhibit a high
signal on unenhanced T1-weighted sequences. This can make
qualitative analysis of the degree of enhancement within these
lesions difﬁcult. Subtraction imaging of dynamic gadolinium-
enhanced sequences will remove any preexisting T1 signal
and thus facilitate detection of lesion enhancement (5). Our
study included two patients presenting with T1 hyperintense
large hepatic nodules with absence enhancement in the arterial
phase as conﬁrmed by subtraction technique suggesting the
possibility of dysplastic nodules which was conﬁrmed via ultra-
sound guided biopsy in both patients.
Radiofrequency ablation and cryoablation are being used
with increased frequency for treatment of malignancies in the
liver, kidneys, and other organs. The goal of either procedure
is complete tumor necrosis. Postprocedural cross-sectional
imaging is used to analyze the lesion for the presence of recur-
rent or residual neoplasm. This is a critical determination in the
management of these patients, and subtraction imaging isideally suited for such a role. Subtraction can make subtle
enhancement within a tumor more conspicuous and can
remove a high T1 signal, which is often present because of coag-
ulation necrosis. It can also help differentiate the smooth, indis-
tinct peritumoral enhancement seen in benign post-treatment
hyperemia from the discontinuous nodular enhancement of
viable tumor (6,7). Our study included ﬁve patients having
lesions with previous diagnosis of hepatocellular carcinoma
managed by radiofrequency ablation with absence of enhance-
ment in the arterial phase as conﬁrmed by the subtraction
images suggesting the diagnosis of post-ablation necrosis. Five
patients had lesions with previous diagnosis of hepatocellular
carcinoma managed by chemoembolization showing retained
T1 hyperintense lipidol particles out of which two patients
showed positive enhancement of the lesions in the arterial phase
denoting tumor recurrence and three patients had absent
enhancement denoting absence of recurrent active tumor tissue.
Complex renal cysts often show a high signal on unen-
hanced T1-weighted sequences due to the presence of either
intracystic hemorrhage or proteinaceous debris. These cysts
are hyperdense on CT. Subtraction imaging has been shown
to be highly sensitive for detection of enhancement within
these lesions and thus for accurate classiﬁcation as either
benign hemorrhagic cysts or cystic renal cell carcinomas. Sub-
traction imaging should be used for analysis of enhancement
within this subset of cystic renal masses on MRI because the
Fig. 8 MRI images of the kidneys: precontrast T1W image with fat suppression (A) and postcontrast T1W image in the arterial phase of
enhancement with fat suppression (B) showing a small cortical renal lesion (arrows) exhibiting a hyperintense signal in both images.
Subtraction image shows absence of enhancement within the lesion conﬁrming the diagnosis of hemorrhagic cortical renal cyst.
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result in false-negative results. MRI is also not subject to
pseudoenhancement artifact, which can limit evaluation of
small intraparenchymal renal masses on CT because of a cor-
rection process that artifactually increases attenuation values
(1). Four patients in our study presented with T1W hyperin-
tense renal cortical lesions. Subtraction images showed
absence of enhancement within the lesions conﬁrming the diag-
nosis of hemorrhagic cortical renal cysts.
Subtraction imaging may also be useful for imaging the
gallbladder in situations in which the differential diagnosis is
between tumefactive sludge and wall thickening from neo-
plasm. Whereas sonography using color or power Doppler
or CT performed with and without contrast material can sug-
gest the diagnosis of neoplasm by showing the presence of
either blood ﬂow or enhancement within the area in question,
MRI with subtraction imaging can aid in making a more
conﬁdent diagnosis. This is especially true in cases of early car-
cinoma when there is no detectable extramural disease (4).
Four patients in our study presented with T1W hyperintense
lesions within the gall bladder lumen. In all of the four patients
subtraction images showed absence of enhancement within the
lesions conﬁrming the diagnosis of intraluminal biliary sludge
and excluding the presence of a neoplastic process.Subtraction of high-resolution images can aid in excluding
features that suggest malignancy in complex cystic adnexal
masses such as solid enhancing components like papillary pro-
jections and mural or septal nodules. In our study ten patients
presented with T1W hyperintense ovarian cystic lesions (4).
Subtraction images showed absent enhancement in the lesions
in the six patients with diagnosis of chocolate cyst. The lesions
in the two patients diagnosed with mucinous cystadenoma
showed internal thin enhancing septations within the lesions
with absent enhancing solid component while the lesions in
the two patients diagnosed with mucinous cystadenocarci-
noma showed multiple mural solid enhancing nodules seen
along the walls of the lesions.
Lloyd et al. (8) concluded in a study performed on different
T1W hyperintense lesions in the head and neck that subtraction
technique is useful in evaluating the degree of enhancement in
such lesions and in differentiating hemorrhagic cystic lesions
from neoplastic masses likely choroidal melanoma which is
characterized by short relaxation times and a high signal in
the T1W sequence. This was matching with the ﬁndings in our
study which included nine patients presenting with head and
neck lesions. Five patients presented with T1W hyperintense
intraocular lesions all of which were located along the choroidal
lining of the globe. Subtraction images detected enhancement
Fig. 9 MRI images of the pancreas: precontrast T1W image with fat suppression (A) and postcontrast T1W image in the arterial phase
of enhancement with fat suppression (B) showing a lesion within the tail of pancreas exhibiting a hyperintense signal in both images
denoting high proteinaceous content within the lesion. Subtraction image shows absence of enhancement within the lesion apart from tiny
enhancing papillary projections seen along its left lateral wall (arrow). The diagnosis of solid papillary neoplasm was conﬁrmed
histopathologically.
Fig. 10 Pre and postcontrast enhanced T1WMRI images with fat suppression (A and B) of the pelvis in a female patient showing a large
ovarian lesion exhibiting a hyperintense signal in both images. Subtraction image (C) shows absent enhancement within the lesion
conﬁrming its cystic nature and the possibility of an ovarian chocolate cyst was suggested and was conﬁrmed histopathologically.
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Fig. 11 Pre and postcontrast enhanced T1WMRI images with fat suppression (A and B) of the pelvis in a female patient showing a large
ovarian lesion exhibiting a hyperintense signal in both images. Subtraction image (C) shows internal thin enhancing septations within the
lesion with absent enhancing solid component conﬁrming its cystic nature. The possibility of a mucinous cystic neoplastic ovarian lesion of
a benign nature was suggested. The diagnosis of ovarian mucinous cystadenoma was conﬁrmed histopathologically.
Fig. 12 Pre and postcontrast enhanced T1WMRI images with fat suppression (A and B) of the pelvis in a female patient showing a large
ovarian lesion exhibiting a hyperintense signal in both images. Subtraction image (C) shows multiple mural solid enhancing nodules seen
along the wall of the lesion (arrows). The possibility of a mucinous ovarian cystic neoplasm probably of malignant nature was suggested
and was conﬁrmed histopathologically.
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Subtraction imaging 919within the lesions conﬁrming the diagnosis of choroidal
melanoma and differentiating them from suprachoroidal
hemorrhage. Four patients presented with non neoplastic
hemorrhagic cysts with absent enhancement, two of which were
located in the parotid gland and two in the masseter muscle.
In conclusion, Subtraction MRI, used since long time for
MR angiography, is a still underused, though very helpful tool,
in non-vascularMRI applications. It can unambiguously assess
post Gadolinium enhancement in those lesions which show ini-
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